Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $20.47 and traded as high as $20.97. Extendicare shares last traded at $20.97, with a volume of 52,511 shares traded.
Analysts Set New Price Targets
EXETF has been the topic of a number of analyst reports. Royal Bank Of Canada reiterated an “outperform” rating on shares of Extendicare in a research report on Friday, August 14th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Extendicare in a research report on Monday, October 26th. Five investment analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.
Get Our Latest Stock Analysis on Extendicare
Extendicare Trading Up 4.0%
The firm’s fifty day simple moving average is $20.47 and its 200-day simple moving average is $21.66.
Extendicare Company Profile
Extendicare Inc. is a Canadian provider of continuing health care and senior living services. The company operates long-term care homes and retirement communities, serving older adults who require residential care, assistance with daily living, or supportive housing. Through its ParaMed business, Extendicare also provides home health-care services, including nursing, personal support, rehabilitation, and other care delivered in patients’ homes. In addition, the company offers management and consulting services to health-care and senior living operators through its Extendicare Assist platform.
Featured Articles
- Five stocks we like better than Extendicare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
